{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:38:32Z","timestamp":1793425112410,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","award":["RZ2300007534"],"award-info":[{"award-number":["RZ2300007534"]}],"id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703793"],"award-info":[{"award-number":["81703793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360882"],"award-info":[{"award-number":["82360882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304826"],"award-info":[{"award-number":["82304826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["824RC522"],"award-info":[{"award-number":["824RC522"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117717","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:11:56Z","timestamp":1768691516000},"page":"117717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cajanolactone A alleviates high-fat diet-induced MAFLD by modulating liver de novo lipogenesis, inflammatory signaling, and bile acid composition in the gut-liver axis"],"prefix":"10.1016","volume":"246","author":[{"given":"Zaibin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-2066","authenticated-orcid":false,"given":"Zhuohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International Consensus Panel, MAFLD: a Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2026.117717_b0015","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.immuni.2025.03.017","article-title":"Acute exposure to high-fat diet impairs ILC3 functions and gut homeostasis","volume":"58","author":"Xiong","year":"2025","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.bcp.2026.117717_b0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5","key":"10.1016\/j.bcp.2026.117717_b0030","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","article-title":"Physiological and pathological roles of lipogenesis","volume":"5","author":"Jeon","year":"2023","journal-title":"Nat. Metab."},{"issue":"48","key":"10.1016\/j.bcp.2026.117717_b0035","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-kappaB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2026.117717_b0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","article-title":"Inflammation and the Metabolic Syndrome: the Tissue-specific Functions of NF-\u03baB","volume":"27","author":"Catrysse","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117717_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149677","article-title":"Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in mice","volume":"11","author":"Zeng","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2026.117717_b0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117717_b0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/microorganisms9050957","article-title":"Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41387-024-00306-1","article-title":"Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice","volume":"14","author":"Panyod","year":"2024","journal-title":"Nutr. Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41420-025-02312-3","article-title":"Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"He","year":"2025","journal-title":"Cell Death Discov."},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.117717_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0080","doi-asserted-by":"crossref","first-page":"19648","DOI":"10.1038\/s41598-024-69764-y","article-title":"NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease","volume":"14","author":"Osman","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102788","article-title":"NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors","volume":"17","author":"Khanmohammadi","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"issue":"5","key":"10.1016\/j.bcp.2026.117717_b0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/j.bcp.2026.117717_b0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117717_b0100","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.bcp.2026.117717_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153290","article-title":"Cajanolactone a, a stilbenoid from cajanus cajan, prevents ovariectomy-induced obesity and liver steatosis in mice fed a regular diet","volume":"78","author":"Luo","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117717_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111491","article-title":"Cajanolactone a, a stilbenoid from Cajanus cajan, inhibits energy intake and lipid synthesis\/storage, and promotes energy expenditure in ovariectomized mice","volume":"138","author":"Luo","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117717_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.695561","article-title":"Cajanolactone a, a Stilbenoid from Cajanus canjan (L.) Millsp, Prevents High-Fat Diet-Induced Obesity via Suppressing Energy Intake","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117717_b0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/molecules24020271","article-title":"Cajanolactone a from Cajanus cajan Promoted Osteoblast Differentiation in Human Bone Marrow Mesenchymal Stem Cells via Stimulating Wnt\/LRP5\/\u03b2-Catenin Signaling","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117717_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2026.117717_b0135","doi-asserted-by":"crossref","DOI":"10.26599\/FMH.2024.9420002","article-title":"Cornus officinalis vinegar alters the gut microbiota, regulating lipid droplet changes in nonalcoholic fatty liver disease model mice","volume":"1","author":"Cao","year":"2024","journal-title":"Food & Medicine Homology."},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0140","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1002\/imt2.69","article-title":"New insights into the mechanisms of high-fat diet mediated gut microbiota in chronic diseases","volume":"2","author":"Chen","year":"2023","journal-title":"iMeta"},{"issue":"3","key":"10.1016\/j.bcp.2026.117717_b0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117717_b0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117717_b0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.06.009","article-title":"Progress and challenges of selective Farnesoid X Receptor modulation","volume":"191","author":"Massafra","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117717_b0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","article-title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bcp.2026.117717_b0175","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.3390\/cimb46070376","article-title":"MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development","volume":"46","author":"Khaznadar","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117717_b0180","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.3390\/cells10112959","article-title":"The Gut-Liver Axis in Chronic Liver Disease: a Macrophage Perspective","volume":"10","author":"De Muynck","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2026.117717_b0185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/nu15051123","article-title":"The Inter-Organ Crosstalk reveals an Inevitable link between MAFLD and Extrahepatic Diseases","volume":"15","author":"Tsutsumi","year":"2023","journal-title":"Nutrients"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:40:52Z","timestamp":1778056852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":37,"alternative-id":["S0006295226000481"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117717","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cajanolactone A alleviates high-fat diet-induced MAFLD by modulating liver de novo lipogenesis, inflammatory signaling, and bile acid composition in the gut-liver axis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117717"}}